Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore the key differences between permissioned and permissionless systems in one concise intro. This overview highlights tradeoffs in security, scalability, and governance to help you decide which model suits your project.
21,471 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
Bank of America upgrades Oracle to Buy, signaling potential upside as AI-driven cloud demand and a massive backlog cr...
Bluesky is carving a new path in social media by using an open, federated protocol. This article explains what Bluesk...
Bitcoin has cooled from its peak, but a smarter buy may lie in a scalable altcoin. This article breaks down why Polyg...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
If federal foreclosure protections vanish, the housing market could see a surge of distressed properties. This articl...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
Political rhetoric can shake markets and impact wallets. This article breaks down how trump’s “election integrity arm...
A quiet-upstart tech company just got upgraded by analysts after solid earnings. This under-the-radar growth stock ma...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...